Πηγή: Marketwire
NEW YORK, NY--(Marketwire - Mar 1, 2012) - Major Pharmaceutical firms have
performed admirably in the first couple months of the year. In Europe, firms
are putting more emphasis on cutting costs and increasing exposure to emerging
markets. Meanwhile U.S. manufacturers are benefiting from an improving domestic
economy. The iShares Dow Jones U.S. Pharmaceuticals Index Fund is up roughly
3.4 percent over the last month -- outperforming the Dow Jones Industrial
Average. The Paragon Report examines the outlook for companies in the Drug
Manufacturers - Major Industry and provides equity research on GlaxoSmithKline
Plc (NYSE: GSK) (LSE: GSK) and Merck & Co. Inc. (NYSE: MRK). Access to the
full company reports can be found at:
The Eurozone debt crisis is taking a toll on Big Pharma's European profits.
A recent review in The New York Times says that the profits, and hence
the share price, of 'Big Pharma' is set to remain stagnant in Europe until at
least 2014. Budget cuts mean that many European governments are not willing to
pay as much for pills, Stephanie Novak of the New York Times reports.
European pharmaceutical companies have been successful in emerging markets
in the last five years, helping to offset troubles at home, Novak reports.
Meanwhile, American companies do not rely as much on overseas revenue because
of their large domestic market.
The Paragon Report provides investors with an excellent first step in their
due diligence by providing daily trading ideas, and consolidating the public
information available on them. For more investment research on the Drug
Manufacturers - Major Industry register with us free at www.paragonreport.com and get exclusive access to our numerous stock reports and industry
newsletters.
UK-based GlaxoSmithKline plc, together with its subsidiaries, engages in
the discovery, development, manufacture, and marketing of pharmaceutical
products, over the counter (OTC) medicines, and health-related consumer
products worldwide. GlaxoSmithKline last week announced it was recalling
394,230 bottles of the blood pressure drug DynaCirc CR.
Merck & Co., Inc. (Merck) is a global health care company. Merck
delivers health solutions through its prescription medicines, vaccines,
biologic therapies, animal health, and consumer care products. It operates in
four segments: Pharmaceutical, Animal Health, Consumer Care and Alliances.